Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Clinical trial NCT05185947 · COMPLETED

Trial details

NCT number: NCT05185947
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gynecologic Cancer Gynecologic Neoplasms Peritoneal Carcinomatosis Peritoneal Neoplasms Ovarian Cancer Ovarian Neoplasms Colorectal Cancer Colorectal Neoplasms Appendiceal Cancer Appendiceal Neoplasms Cholangiocarcinoma Breast Cancer

Start date: 2022-10-13
Primary completion: 2025-01-27
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.